Feb 01, 2024 / 01:00PM GMT
Presentation
Feb 01, 2024 / 01:00PM GMT
=====================
Corporate Participants
=====================
* Alan Hippe
Roche Holding AG - Chief Financial & Information Officer
* Bruno Eschli
Roche Holding AG - Head of IR
* Matthew Sause
Roche Diagnostics Corporation - CEO
* Teresa A. Graham
Roche Holding AG - CEO of Roche Pharmaceuticals
* Thomas Schinecker
Roche Holding AG - CEO
=====================
Conference Call Participants
=====================
* Charles David Mabbutt
Morgan Stanley, Research Division - Research Associate
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - European Head of Biopharma
* John Priestner
JPMorgan Chase & Co, Research Division - Research Analyst
* Matthew Weston
UBS Investment Bank, Research Division - Analyst
* Richard J. Parkes
BNP Paribas Exane, Research Division - Head of Pharmaceutical and Biotechnology & Analyst
* Richard Wagner
* Sachin Jain
Roche Holding AG
(LTS:0QOK)
CHF
265.9
-1.15 (-0.43%)
Market Cap: 211.97 Bil
Enterprise Value: 237.60 Bil
PE Ratio: 19.87
PB Ratio: 7.24
GF Score: 85/100 Full Year 2023 Roche Holding AG Earnings Presentation Transcript
Feb 01, 2024 / 01:00PM GMT
Release Date Price:
CHF235.78
(-4.73%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot